Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

CD40 and autoimmunity: the dark side of a great activator.

Peters AL, Stunz LL, Bishop GA.

Semin Immunol. 2009 Oct;21(5):293-300. doi: 10.1016/j.smim.2009.05.012. Review.

2.

The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.

Toubi E, Shoenfeld Y.

Autoimmunity. 2004 Sep-Nov;37(6-7):457-64. Review.

PMID:
15621572
3.

Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.

Dejica DI, Manea EM.

Roum Arch Microbiol Immunol. 2006 Jan-Jun;65(1-2):66-74. Review.

PMID:
17877113
4.

The role of CD40-CD154 interaction in cell immunoregulation.

Xu Y, Song G.

J Biomed Sci. 2004 Jul-Aug;11(4):426-38. Review.

PMID:
15153777
5.
6.
7.

Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.

Law CL, Grewal IS.

Adv Exp Med Biol. 2009;647:8-36. doi: 10.1007/978-0-387-89520-8_2. Review.

PMID:
19760064
8.

Regulation of CD40 ligand expression in systemic lupus erythematosus.

Crow MK, Kirou KA.

Curr Opin Rheumatol. 2001 Sep;13(5):361-9. Review.

PMID:
11604589
9.

Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.

Howard LM, Miller SD.

Autoimmunity. 2004 Aug;37(5):411-8. Review.

PMID:
15621565
10.

The CD40/CD154 receptor/ligand dyad.

Schönbeck U, Libby P.

Cell Mol Life Sci. 2001 Jan;58(1):4-43. Review.

PMID:
11229815
11.

CD40 signaling and autoimmunity.

Cheng G, Schoenberger SP.

Curr Dir Autoimmun. 2002;5:51-61. Review. No abstract available.

PMID:
11826760
12.

CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.

Alaaeddine N, Hassan GS, Yacoub D, Mourad W.

Clin Dev Immunol. 2012;2012:490148. doi: 10.1155/2012/490148. Epub 2011 Oct 24. Review.

13.

Prospects for CD40-directed experimental therapy of human cancer.

Tong AW, Stone MJ.

Cancer Gene Ther. 2003 Jan;10(1):1-13. Review.

PMID:
12489023
14.

The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.

Engel D, Seijkens T, Poggi M, Sanati M, Thevissen L, Beckers L, Wijnands E, Lievens D, Lutgens E.

Semin Immunol. 2009 Oct;21(5):308-12. doi: 10.1016/j.smim.2009.06.004. Epub 2009 Jul 17. Review.

PMID:
19616449
15.

CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus.

Grammer AC, Lipsky PE.

Arthritis Rheum. 2002 Jun;46(6):1417-29. Review. No abstract available.

16.

The role of CD40 and CD154/CD40L in dendritic cells.

Ma DY, Clark EA.

Semin Immunol. 2009 Oct;21(5):265-72. doi: 10.1016/j.smim.2009.05.010. Epub 2009 Jun 12. Review. Erratum in: Semin Immunol. 2010 Jun;22(3):190.

17.

CD40-CD154 interaction in experimental and human disease (review).

Biancone L, Cantaluppi V, Camussi G.

Int J Mol Med. 1999 Apr;3(4):343-53. Review.

PMID:
10085405
18.

CD40 and tolerance induction.

Karimi MH, Pourfathollah AA.

Iran J Allergy Asthma Immunol. 2012 Mar;11(1):1-13. doi: 011.01/ijaai.113. Review.

19.

The role of CD40 ligand in systemic lupus erythematosus.

Yazdany J, Davis J.

Lupus. 2004;13(5):377-80. Review.

PMID:
15230296
20.

CD40 and CD154 in cell-mediated immunity.

Grewal IS, Flavell RA.

Annu Rev Immunol. 1998;16:111-35. Review.

PMID:
9597126

Supplemental Content

Support Center